Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The choice of technique should consider patient characteristics and lesion size
Loading Phase (Weeks 1-4): 2 to 2.5 mg twice weekly (Monday/Thursday schedule) Maintenance Phase (Weeks 5+): 2 mg once every 7 to 14 days Administration: Subcutaneous injection, location flexible due to systemic distribution Total Cycle: 8 to 12 weeks with 4 to 8 weeks off between cycles The convenience of twice-weekly dosing during loading and weekly or biweekly dosing during maintenance fits easily into Retatrutide schedules
GHK-Cu is best explained as a regeneration peptide that helps the skin repair and rebuild itself, while Botox-like or simple collagen-boosting peptides usually focus on one specific action
Gusev EI, Martynov MY, Kostenko EV, et al
Researchers believe the peptide may bind to carrier proteins in the blood or exist as part of a larger precursor molecule to extend its functional duration in the body
In September 2023 the FDA placed BPC-157 in Category 2 of its 503A interim bulk-substances policy, citing immunogenicity and peptide-characterization concerns, effectively excluding it from the 503A compounding bulk-substances list
